Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Young investigators honored in fight against kidney cancer

Young investigators honored in fight against kidney cancer

Diabetes and a history of heart disease increase the risk of heart problems for elderly breast cancer patients on trastuzumab

Diabetes and a history of heart disease increase the risk of heart problems for elderly breast cancer patients on...

Double-agent chemotherapy gives survival benefit to patients over 70 with lung cancer; thus current monotherapy-only strategy should be revised

Double-agent chemotherapy gives survival benefit to patients over 70 with lung cancer; thus current monotherapy...

New ASCO guidelines on chemotherapy and resistance assays

New ASCO guidelines on chemotherapy and resistance assays

ecancerHub - A new approach to cancer communication

ecancerHub - A new approach to cancer communication

Rigid and fragile chromosomes: the double-edged sword of tumour cells

Rigid and fragile chromosomes: the double-edged sword of tumour cells

Erlotinib nearly triples progression-free survival compared with standard chemo in patients with the most common form of lung cancer

Erlotinib nearly triples progression-free survival compared with standard chemo in patients with the most common...

Denosumab approved in Europe

Denosumab approved in Europe

Study predicts improved survival in primary mediastinal nonseminomatous germ cell tumours

Study predicts improved survival in primary mediastinal nonseminomatous germ cell tumours

FDA panel recommends brentuximab vedotin for accelerated approval for lymphomas

FDA panel recommends brentuximab vedotin for accelerated approval for lymphomas

More from ecancer